A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma

NCT00359294 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped Low recruitment

Conditions

Solid Tumors
Lymphoma

Interventions

DRUG: PM00104

Sponsor

PharmaMar